Literature DB >> 25724180

TRIM24 is upregulated in human gastric cancer and promotes gastric cancer cell growth and chemoresistance.

Zhi-Feng Miao1, Zhen-Ning Wang, Ting-Ting Zhao, Ying-Ying Xu, Jian-Hua Wu, Xing-Yu Liu, Hao Xu, Yi You, Hui-Mian Xu.   

Abstract

The tripartite motif protein tripartite motif-containing 24 (TRIM24) is involved in human cancer progression. However, the expression pattern and biological roles of TRIM24 in human gastric cancer have not been studied. Here, we report that expression of TRIM24 protein was upregulated in 65 of 133 gastric cancer specimens. TRIM24 upregulation positively correlated with clinical stage, local invasion, and poor patient prognosis. We overexpressed TRIM24 by transfection in SGC-7901 cells and used an siRNA strategy to knock down TRIM24 in MKN-1 cells. MTT and colony formation assays showed that transfection of TRIM24 plasmid accelerated, while its depletion inhibited cell proliferation rate. TRIM24 overxpression also induced chemoresistance to 5-FU in gastric cancer cells. Further analysis showed that TRIM24 overexpression upregulated cyclin D1 and Akt phosphorylation. Akt inhibitor LY294002 reversed the role of TRIM24 on chemoresistance. In conclusion, our study shows that TRIM24 is overexpressed in human gastric cancer and accelerates cell growth as well as induce chemoresistance, possibly through the Akt pathway.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25724180     DOI: 10.1007/s00428-015-1737-4

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  21 in total

1.  Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.

Authors:  Supak Yothaisong; Hasaya Dokduang; Anchalee Techasen; Nisana Namwat; Puangrat Yongvanit; Vajarabhongsa Bhudhisawasdi; Anucha Puapairoj; Gregory J Riggins; Watcharin Loilome
Journal:  Tumour Biol       Date:  2013-07-06

Review 2.  TIF1 alpha: a chromatin-specific mediator for the ligand-dependent activation function AF-2 of nuclear receptors?

Authors:  B Le Douarin; A L Nielsen; J You; P Chambon; R Losson
Journal:  Biochem Soc Trans       Date:  1997-05       Impact factor: 5.407

3.  A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins.

Authors:  S Zhong; L Delva; C Rachez; C Cenciarelli; D Gandini; H Zhang; S Kalantry; L P Freedman; P P Pandolfi
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

4.  The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas.

Authors:  S Klugbauer; H M Rabes
Journal:  Oncogene       Date:  1999-07-29       Impact factor: 9.867

5.  Prognostic significance of TRIM24/TIF-1α gene expression in breast cancer.

Authors:  Monique Chambon; Béatrice Orsetti; Marie-Laurence Berthe; Caroline Bascoul-Mollevi; Carmen Rodriguez; Vanessa Duong; Michel Gleizes; Sandrine Thénot; Frédéric Bibeau; Charles Theillet; Vincent Cavaillès
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

6.  TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway.

Authors:  L-H Zhang; A-A Yin; J-X Cheng; H-Y Huang; X-M Li; Y-Q Zhang; N Han; X Zhang
Journal:  Oncogene       Date:  2014-01-27       Impact factor: 9.867

7.  Pyrophosphatase overexpression is associated with cell migration, invasion, and poor prognosis in gastric cancer.

Authors:  Sang-Ho Jeong; Gyung Hyuck Ko; Young Hyun Cho; Young-Joon Lee; Bok-Im Cho; Woo-Song Ha; Sang-Kyung Choi; Jae Won Kim; Chang Won Lee; Yoon Seok Heo; Seok Hwan Shin; Jiyun Yoo; Soon-Chan Hong
Journal:  Tumour Biol       Date:  2012-07-14

8.  Apoptosis index correlates with chemotherapy efficacy and predicts the survival of patients with gastric cancer.

Authors:  Yongning Jia; Bin Dong; Lei Tang; Yiqiang Liu; Hong Du; Peng Yuan; Aiwen Wu; Jiafu Ji
Journal:  Tumour Biol       Date:  2012-03-01

9.  LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells.

Authors:  Jung-Young Shin; Jeong-Oh Kim; Suk Kyeong Lee; Hiun-Suk Chae; Jin-Hyoung Kang
Journal:  BMC Cancer       Date:  2010-08-13       Impact factor: 4.430

10.  TRIM24 links a non-canonical histone signature to breast cancer.

Authors:  Wen-Wei Tsai; Zhanxin Wang; Teresa T Yiu; Kadir C Akdemir; Weiya Xia; Stefan Winter; Cheng-Yu Tsai; Xiaobing Shi; Dirk Schwarzer; William Plunkett; Bruce Aronow; Or Gozani; Wolfgang Fischle; Mien-Chie Hung; Dinshaw J Patel; Michelle Craig Barton
Journal:  Nature       Date:  2010-12-16       Impact factor: 49.962

View more
  22 in total

1.  Histone H3 lysine 23 acetylation is associated with oncogene TRIM24 expression and a poor prognosis in breast cancer.

Authors:  Li Ma; Lili Yuan; Jing An; Michelle C Barton; Qingyuan Zhang; Zhaoliang Liu
Journal:  Tumour Biol       Date:  2016-09-16

2.  TRIM58 suppresses the tumor growth in gastric cancer by inactivation of β-catenin signaling via ubiquitination.

Authors:  Xiaowen Liu; Ziwen Long; Hong Cai; Shengjia Yu; Jianghong Wu
Journal:  Cancer Biol Ther       Date:  2019-11-21       Impact factor: 4.742

3.  Overexpression of TRIM24 is correlated with the progression of human cervical cancer.

Authors:  Li Lin; Weihua Zhao; Bo Sun; Xinyu Wang; Qiao Liu
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

4.  Cross-talk between chromatin acetylation and SUMOylation of tripartite motif-containing protein 24 (TRIM24) impacts cell adhesion.

Authors:  Srikanth Appikonda; Kaushik N Thakkar; Parantu K Shah; Sharon Y R Dent; Jannik N Andersen; Michelle C Barton
Journal:  J Biol Chem       Date:  2018-03-09       Impact factor: 5.157

5.  TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer.

Authors:  Anna C Groner; Laura Cato; Jonas de Tribolet-Hardy; Tiziano Bernasocchi; Hana Janouskova; Diana Melchers; René Houtman; Andrew C B Cato; Patrick Tschopp; Lei Gu; Andrea Corsinotti; Qing Zhong; Christian Fankhauser; Christine Fritz; Cédric Poyet; Ulrich Wagner; Tiannan Guo; Ruedi Aebersold; Levi A Garraway; Peter J Wild; Jean-Philippe Theurillat; Myles Brown
Journal:  Cancer Cell       Date:  2016-05-26       Impact factor: 31.743

6.  TRIM24 protein promotes and TRIM32 protein inhibits cardiomyocyte hypertrophy via regulation of dysbindin protein levels.

Authors:  Ankush Borlepawar; Ashraf Yusuf Rangrez; Alexander Bernt; Lynn Christen; Samuel Sossalla; Derk Frank; Norbert Frey
Journal:  J Biol Chem       Date:  2017-05-02       Impact factor: 5.157

7.  TRIM24 promotes the aggression of gastric cancer via the Wnt/β-catenin signaling pathway.

Authors:  Ziling Fang; Jun Deng; Ling Zhang; Xiaojun Xiang; Feng Yu; Jun Chen; Miao Feng; Jianping Xiong
Journal:  Oncol Lett       Date:  2017-01-17       Impact factor: 2.967

Review 8.  TRIM family contribute to tumorigenesis, cancer development, and drug resistance.

Authors:  Ning Huang; Xiaolin Sun; Peng Li; Xin Liu; Xuemei Zhang; Qian Chen; Hong Xin
Journal:  Exp Hematol Oncol       Date:  2022-10-19

9.  Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF.

Authors:  James Bennett; Oleg Fedorov; Cynthia Tallant; Octovia Monteiro; Julia Meier; Vicky Gamble; Pavel Savitsky; Graciela A Nunez-Alonso; Bernard Haendler; Catherine Rogers; Paul E Brennan; Susanne Müller; Stefan Knapp
Journal:  J Med Chem       Date:  2015-05-20       Impact factor: 7.446

Review 10.  Roles of E3 ubiquitin ligases in gastric cancer carcinogenesis and their effects on cisplatin resistance.

Authors:  Huizhen Wang; Yida Lu; Mingliang Wang; Youliang Wu; Xiaodong Wang; Yongxiang Li
Journal:  J Mol Med (Berl)       Date:  2021-01-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.